We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
5 policies in 2019 will affect China’s pharmaceutical market in 2020, which mainly involve China’s national medical insurance payment and pharmaceutical product cost control.
In Premier Li’s meeting the press recently after close of the two sessions, he said, “We will largely reduce the import tariff of oncology drugs that are badly needed by the people and patients and strive to achieve zero tariff”.